(VIANEWS) – The NASDAQ ended the session with Vertex Pharmaceuticals jumping 4.83% to $263.09 on Monday, following the last session’s upward trend. NASDAQ jumped 1.43% to $10,798.35, following the last session’s upward trend on what was an all-around up trend trading session today.
Today’s last reported volume for Vertex Pharmaceuticals is 3443820, 103.72% above its average volume of 1690470.
Vertex Pharmaceuticals’s last close was $263.09, 10.13% under its 52-week high of $292.75.
The company’s growth estimates for the present quarter and the next is 13.8% and 1.1%, respectively.
Vertex Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 7.57B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Vertex Pharmaceuticals’s stock is considered to be oversold (<=20).
Vertex Pharmaceuticals’s Stock Yearly Top and Bottom Value
Vertex Pharmaceuticals’s stock is valued at $263.09 at 20:28 EST, way under its 52-week high of $292.75 and way higher than its 52-week low of $176.36.
Vertex Pharmaceuticals’s Moving Average
Vertex Pharmaceuticals’s worth is below its 50-day moving average of $265.47 and way higher than its 200-day moving average of $226.32.
More news about Vertex Pharmaceuticals (VRTX).